• China market stabilizing as Sinopharm partnership consolidates
• SE Asia sales growing strongly with new regional distribution
• European growth dampened by Russia-Ukraine war
• US market uncertainty due to new government policies

Uscom's H1 FY25 results are in-line with last year, reflecting major disruptions in all major markets - US, Europe and China. While China's growth has now stabilized and is warming for recovery, the US and Europe both remain anemic and uncertain. In China, the signing of a collaborative partnership with Sinopharm, China's biggest distribution platform for health products, was an important highlight. However, China remained a market in reform with interruptions to hospital purchasing and distribution pathways limiting normal health related sales activities. In SE Asia, Uscom's sales have grown strongly in the last 12 months since establishing a regional HQ in Singapore and appointing a local sales organization. The anticipated upswing in European activities has been hampered by the ongoing Russia-Ukraine war, resulting in less than expected economic activity and restrained health spending. US medical sales were down as politics consumed the market, with the new US government committed to cutting healthcare services. Uscom continues its global expansion, developing new products and technologies and refining its sector-leading cardiovascular and pulmonary monitoring devices. The company remains bullish on the growth prospects of its products, having invested in a strategy for short, mid and long-term growth based on an expanding international footprint and a target of achieving global scale and strong profitability.

Uscom expects its newly approved products in China, combined with the Sinopharm partnership, to begin boosting revenue in H2 FY25.

While global uncertainty is the certainty for the coming year, Uscom has established a business with multiple regional HQs, an expanded product range, earnings in different currencies and an expanding list of influential partners, all of which will act to mitigate against the threats of volatile global markets inhibiting Uscom's success.